The global semaglutide market is expected to be driven by the surge in the number of patients with type 2 diabetes
With its innovative triple-agonist mechanism and early clinical success, it could very well be the miracle molecule that changes the future of metabolic medicine
Cytotoxic lanthanum oxide nanoparticles sensitize glioblastoma cells to radiation therapy and temozolomide: an in vitro rationale for translational studies
At Elite Primary Care Group, we understand that weight management is a unique journey for every patient
in Proceedings of the 60th Annual Meeting of the Association for Computational Linguistics: System Demonstrations (Association for Computational Linguistics, Stroudsburg, PA, USA)
December 9, 2025 Update on MDL cases With the explosive growth in the use of Ozempic and other GLP-1based weight-loss drugs, its no surprise that the related class action MDL continues to expand